PICS: A New Horizon for Surgical Critical Care

PICS:外科重症监护的新视野

基本信息

  • 批准号:
    9484296
  • 负责人:
  • 金额:
    $ 213.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Despite 30 years of intensive research, morbidity and mortality of sepsis in surgical intensive care unit (ICU) patients remain unacceptably high. Although recent advances in early ICU care have reduced in-hospital mortality, with the aging population a new epidemic of chronic critical illness (CCI) has emerged and its progression into what we call the persistent inflammation, immunosuppression and catabolism syndrome (PICS) has unacceptable morbid long-term consequences. Our overarching hypothesis is that PICS is now a predominant clinical trajectory in the surgical ICU patients after sepsis, and is the greatest, near-term clinical challenge in surgical ICUs. We further hypothesize that PICS is caused, at least in part, by dysregulated myelopoiesis and expansion of myeloid-derived suppressor cells (MDSCs), aggravated by aging and largely driven by acute kidney injury (AKI), resulting in imbalance of angiogenic and anti-angiogenic factors. This Sepsis and Critical Illness Research Center (SCIRC) application comprises four projects and five cores drawn from two colleges (Medicine and Public Health and Health Professions) and eight University of Florida Health departments (Surgery, Medicine, Anesthesiology, Biostatistics, Molecular Genetics and Microbiology, Aging and Geriatric Research, and Physical Therapy) and will address the following questions in four projects: #1a) What is the incidence and early risk factors for CCI in septic surgical ICU patients and what are the long-term cognitive and functional consequences? #1b) Can novel biomarkers predict, early, which patients will develop CCI, and, later, which CCI patients will have morbid long-term outcomes (i.e., PICS)? #2) Is PICS inherently driven by dysregulation in myelopoiesis and inappropriate MDSC expansion, promoting persistent inflammation, immunosuppression and catabolism?; #3) Does AKI, through dysregulation of anti-angiogenic and angiogenic cytokines, drive the expansion of MDSCs, inflammation, and anti-angiogenesis?; and #4) Does CCI contribute significantly to muscle atrophy, especially in mechanically ventilated patients' diaphragms and extremities, and will resistance exercise improve muscle strength, reduce inflammation, and alter the trajectory of CCI away from the PICS phenotype? We will study 400 surgical ICU patients who develop sepsis for at least one year, and use murine models of chronic polymicrobial sepsis for mechanistic studies and interventional methods. We recognize that no single therapeutic intervention will prevent PICS, but the SCIRC's overall goal is to understand the prevalence and pathogenesis of this new syndrome at a mechanistic level. Only through multi-disciplinary translational research by basic and clinical scientists with diverse expertise in critical care medicine, physical therapy, immunology, molecular biology, and understanding of muscle, kidney, and aging physiology, can CCI progression into PICS be understood and novel therapies developed.
描述(由申请人提供):尽管经过30年的深入研究,外科重症监护室(ICU)患者脓毒症的发病率和死亡率仍然高得不可接受。尽管最近ICU早期护理的进展降低了住院死亡率,但随着人口老龄化,出现了一种新的慢性危重病(CCI)流行病,其进展为我们所说的持续性炎症,免疫抑制和卡他综合征(PICS),具有不可接受的病态长期后果。我们的总体假设是,PICS现在是外科ICU患者脓毒症后的主要临床轨迹,并且是外科ICU中最大的近期临床挑战。我们进一步假设PICS至少部分是由骨髓生成失调和髓源性抑制细胞(MDSC)扩增引起的,由衰老加重,主要由急性肾损伤(阿基)驱动,导致血管生成和抗血管生成因子失衡。这个败血症和危重病研究中心(SCIRC)的应用程序包括四个项目和五个核心来自两个学院(医学和公共卫生和健康教育)和八个佛罗里达大学卫生部门(外科,医学,麻醉学,生物统计学,分子遗传学和微生物学,衰老和老年研究以及物理治疗),并将在四个项目中解决以下问题:#1a)在脓毒症外科ICU患者中CCI的发病率和早期风险因素是什么,以及长期认知和功能后果是什么?#1b)新的生物标志物能否早期预测哪些患者将发展为CCI,以及随后哪些CCI患者将具有病态的长期结果(即,PICS)?#2)PICS是否由骨髓生成中的失调和不适当的MDSC扩增内在地驱动,从而促进持续性炎症、免疫抑制和catalysis?#3)阿基是否通过抗血管生成和血管生成细胞因子的失调驱动MDSC的扩增、炎症和抗血管生成?和#4)CCI是否显著促进肌肉萎缩,特别是在机械通气患者的横膈膜和四肢中,阻力锻炼是否会改善肌肉力量,减少炎症,并改变CCI的轨迹远离PICS表型?我们将研究400名外科ICU患者,这些患者发生脓毒症至少一年,并使用慢性多微生物脓毒症的小鼠模型进行机制研究和干预方法。我们认识到,没有单一的治疗干预将防止PICS,但SCIRC的总体目标是了解这种新的综合征的发病率和发病机制在一个机械水平。只有通过基础和临床科学家在重症监护医学,物理治疗,免疫学,分子生物学以及对肌肉,肾脏和衰老生理学的理解方面具有不同专业知识的多学科转化研究,才能理解CCI进展为PICS并开发新的治疗方法。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Establishing a continuum of acute kidney injury - tracing AKI using data source linkage and long-term follow-up: Workgroup Statements from the 15th ADQI Consensus Conference.
  • DOI:
    10.1186/s40697-016-0102-0
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Mehta R;Bihorac A;Selby NM;Quan H;Goldstein SL;Kellum JA;Ronco C;Bagshaw SM;Acute Dialysis Quality Initiative (ADQI) Consensus Group
  • 通讯作者:
    Acute Dialysis Quality Initiative (ADQI) Consensus Group
Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure.
Acute kidney injury in 2014: a step towards understanding mechanisms of renal repair.
  • DOI:
    10.1038/nrneph.2014.245
  • 发表时间:
    2015-02
  • 期刊:
  • 影响因子:
    41.5
  • 作者:
    Bihorac, Azra;Kellum, John A.
  • 通讯作者:
    Kellum, John A.
Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis.
  • DOI:
    10.1186/s13613-021-00865-x
  • 发表时间:
    2021-05-20
  • 期刊:
  • 影响因子:
    8.1
  • 作者:
    Guirgis FW;Leeuwenburgh C;Moldawer L;Ghita G;Black LP;Henson M;DeVos E;Holden D;Efron P;Reddy ST;Moore FA
  • 通讯作者:
    Moore FA
Chronic Critical Illness and PICS Nutritional Strategies.
  • DOI:
    10.3390/jcm10112294
  • 发表时间:
    2021-05-25
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Rosenthal MD;Vanzant EL;Moore FA
  • 通讯作者:
    Moore FA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FREDERICK A MOORE其他文献

FREDERICK A MOORE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FREDERICK A MOORE', 18)}}的其他基金

Human Subjects Core
人类受试者核心
  • 批准号:
    8740715
  • 财政年份:
    2014
  • 资助金额:
    $ 213.18万
  • 项目类别:
Epidemiology of Chronic Critical Illness in Surgical ICU Patients After Sepsis
脓毒症后外科 ICU 患者慢性危重疾病的流行病学
  • 批准号:
    8740719
  • 财政年份:
    2014
  • 资助金额:
    $ 213.18万
  • 项目类别:
PICS: A New Horizon for Surgical Critical Care
PICS:外科重症监护的新视野
  • 批准号:
    8740713
  • 财政年份:
    2014
  • 资助金额:
    $ 213.18万
  • 项目类别:
PICS: A New Horizon for Surgical Critical Care
PICS:外科重症监护的新视野
  • 批准号:
    8917992
  • 财政年份:
    2014
  • 资助金额:
    $ 213.18万
  • 项目类别:
Modulating Innate and Adaptive Immunity in Complicated Abdominal Sepsis
调节复杂性腹部脓毒症的先天性和适应性免疫
  • 批准号:
    8367057
  • 财政年份:
    2012
  • 资助金额:
    $ 213.18万
  • 项目类别:
IMPAIRED GUT TRANSIT AND HYPERTONIC SALINE RESUSCITATION/PROJECT 3
肠道运输受损和高渗盐水复苏/项目 3
  • 批准号:
    6813356
  • 财政年份:
    2004
  • 资助金额:
    $ 213.18万
  • 项目类别:
ADMINISTRATIVE CORE/CORE C
行政核心/核心C
  • 批准号:
    6813361
  • 财政年份:
    2004
  • 资助金额:
    $ 213.18万
  • 项目类别:
ROLE OF EARLY GUT DYSFUNCTION IN LATE POSTINJURY MOF
早期肠道功能障碍在损伤后晚期 MOF 中的作用
  • 批准号:
    6659285
  • 财政年份:
    2002
  • 资助金额:
    $ 213.18万
  • 项目类别:
ROLE OF EARLY GUT DYSFUNCTION IN LATE POSTINJURY MOF
早期肠道功能障碍在损伤后晚期 MOF 中的作用
  • 批准号:
    6644314
  • 财政年份:
    2002
  • 资助金额:
    $ 213.18万
  • 项目类别:
ROLE OF EARLY GUT DYSFUNCTION IN LATE POSTINJURY MOF
早期肠道功能障碍在损伤后晚期 MOF 中的作用
  • 批准号:
    6493984
  • 财政年份:
    2001
  • 资助金额:
    $ 213.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 213.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了